Nektar Announces Positive Data on Ovarian Cancer Drug
An experimental drug from Nektar Therapeutics was able to shrink tumors and reduce a cancer biomarker in women with advanced ovarian cancer in a mid-stage study.
5561
Copyright © 2024 | WordPress Theme by MH Themes